RxDoctor Payments Data

Vikram Mayuran, MD

Orthopaedic Surgery of the Spine · Phoenix, AZNPI 1568879773

Payments from drug & device makers

What this record shows

This record is dominated by grants: $60,000 of the $76,438 with a category attached, or 78.5%. Globus Medical accounts for 81.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $60,311 and has fallen 90.1% since, to $5,972 in 2025.

$76,438in general payments, 2019–2025

Across 140 payments — averaging $545.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$62K
  • Alphatec Spine, Inc$7K
  • Medtronic$3K
  • Spineology Inc.$2K
  • Spinal Elements, Inc.$988
  • Expanding Innovations, Inc.$436
  • plus $2K from 12 others

What the payments were for

  • Grants$60,00078%
  • Travel & lodging$9,61813%
  • Food & beverage$6,8209%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,438 in reported general payments places this provider in the 60th percentile of 64 orthopaedic surgery of the spine providers in Arizona.

See all orthopaedic surgery of the spine providers in Arizona

Medicare billing

Part B allowed, 2024
$176,698
Medicare patients
243
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin158$1,654
Pregabalin44$909
Meloxicam150$479
Methocarbamol24$359
Methylprednisolone24$205
Prednisone22$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →